347 related articles for article (PubMed ID: 28124960)
1. [Investigation of in vitro metronidazole resistance in the clinical isolates of Trichomonas vaginalis].
Ertabaklar H; Yaman Karadam S; Malatyalı E; Ertuğ S
Mikrobiyol Bul; 2016 Oct; 50(4):552-558. PubMed ID: 28124960
[TBL] [Abstract][Full Text] [Related]
2. The effect of iron on metronidazole activity against Trichomonas vaginalis in vitro.
Elwakil HS; Tawfik RA; Alam-Eldin YH; Nassar DA
Exp Parasitol; 2017 Nov; 182():34-36. PubMed ID: 28935536
[TBL] [Abstract][Full Text] [Related]
3. The genetic diversity of metronidazole susceptibility in Trichomonas vaginalis clinical isolates in an Egyptian population.
Abdel-Magied AA; El-Kholya EI; Abou El-Khair SM; Abdelmegeed ES; Hamoudaa MM; Mohamed SA; El-Tantawy NL
Parasitol Res; 2017 Nov; 116(11):3125-3130. PubMed ID: 28956167
[TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibility of Trichomonas vaginalis to metronidazole and treatment outcome in vaginal trichomoniasis.
Müller M; Lossick JG; Gorrell TE
Sex Transm Dis; 1988; 15(1):17-24. PubMed ID: 3258675
[TBL] [Abstract][Full Text] [Related]
5. [In vitro susceptibility of Trichomonas vaginalis to metronidazole, ornidazole and proton pump inhibitors pantoprazole and esomeprazole].
Aksoy Gökmen A; Girginkardeşler N; Kilimcioğlu AA; Şirin MC; Özbilgin A
Mikrobiyol Bul; 2016 Jan; 50(1):133-9. PubMed ID: 27058337
[TBL] [Abstract][Full Text] [Related]
6. Resistance of Trichomonas vaginalis to metronidazole: report of the first three cases from Finland and optimization of in vitro susceptibility testing under various oxygen concentrations.
Meri T; Jokiranta TS; Suhonen L; Meri S
J Clin Microbiol; 2000 Feb; 38(2):763-7. PubMed ID: 10655382
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of netropsin dihydrochloride against the viability, cytopathogenicity and hemolytic activity of Trichomonas vaginalis clinical isolates.
Abou Gamra MM; Kamel HH; Ezz Eldin HM; Taha Zahran FM
J Infect Chemother; 2019 Dec; 25(12):955-964. PubMed ID: 31189504
[TBL] [Abstract][Full Text] [Related]
8. The presence of dsRNA virus in Trichomonas vaginalis isolates from symptomatic and asymptomatic Indian women and its correlation with in vitro metronidazole sensitivity.
Malla N; Kaul P; Sehgal R; Gupta I
Indian J Med Microbiol; 2011; 29(2):152-7. PubMed ID: 21654110
[TBL] [Abstract][Full Text] [Related]
9. Trichomonas vaginalis prevalence, incidence, risk factors and antibiotic-resistance in an adolescent population.
Krashin JW; Koumans EH; Bradshaw-Sydnor AC; Braxton JR; Evan Secor W; Sawyer MK; Markowitz LE
Sex Transm Dis; 2010 Jul; 37(7):440-4. PubMed ID: 20351623
[TBL] [Abstract][Full Text] [Related]
10. Lack of association between Mycoplasma hominis and Trichomonas vaginalis symbiosis in relation to metronidazole resistance.
Mabaso N; Tinarwo P; Abbai N
Parasitol Res; 2020 Dec; 119(12):4197-4204. PubMed ID: 33068149
[TBL] [Abstract][Full Text] [Related]
11. High rates of double-stranded RNA viruses and Mycoplasma hominis in Trichomonas vaginalis clinical isolates in South Brazil.
da Luz Becker D; dos Santos O; Frasson AP; de Vargas Rigo G; Macedo AJ; Tasca T
Infect Genet Evol; 2015 Aug; 34():181-7. PubMed ID: 26160539
[TBL] [Abstract][Full Text] [Related]
12. Biological variability of Trichomonas vaginalis clinical isolates from symptomatic and asymptomatic patients.
Hussien EM; El-Sayed HZ; Shaban MM; Salm AM; Rashwan M
J Egypt Soc Parasitol; 2004 Dec; 34(3):979-88. PubMed ID: 15587322
[TBL] [Abstract][Full Text] [Related]
13. In vitro drug susceptibility and doses of metronidazole required for cure in cases of refractory vaginal trichomoniasis.
Lossick JG; Müller M; Gorrell TE
J Infect Dis; 1986 May; 153(5):948-55. PubMed ID: 3486237
[TBL] [Abstract][Full Text] [Related]
14. Distribution of genotypes in relation to metronidazole susceptibility patterns in Trichomonas vaginalis isolated from South African pregnant women.
Mabaso N; Abbai N
Parasitol Res; 2021 Jun; 120(6):2233-2241. PubMed ID: 34002261
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of Conventional Methods with Molecular Methods in the Diagnosis of Trichomonas vaginalis and Investigation of Metronidazole Resistance].
Özel Y; Çavuş İ; Usta A; Vardar Ünlü G; Özbilgin A; Ünlü M
Mikrobiyol Bul; 2023 Oct; 57(4):625-638. PubMed ID: 37885390
[TBL] [Abstract][Full Text] [Related]
16. Potential of bisbenzimidazole-analogs toward metronidazole-resistant Trichomonas vaginalis isolates.
Korosh T; Bujans E; Morada M; Karaalioglu C; Vanden Eynde JJ; Mayence A; Huang TL; Yarlett N
Chem Biol Drug Des; 2017 Oct; 90(4):489-495. PubMed ID: 28296056
[TBL] [Abstract][Full Text] [Related]
17. Comparative in vitro sensitivity to metronidazole of Trichomonas vaginalis with isolates and clones.
Sithithaworn P; Sithithaworn J; Kitjaroen K; Pairojkul C; Ratananurakpong S; Sriswangwonk T
Southeast Asian J Trop Med Public Health; 1989 Jun; 20(2):279-84. PubMed ID: 2609217
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the effect of some medicinal plants on cultured Trichomonas Vaginalis.
Selim MA; Fawzy EM; Abd El-Rahman EM; Abdel Hady RS; Badr MS; Abdel Hamed EF
J Infect Dev Ctries; 2020 Jul; 14(7):793-799. PubMed ID: 32794472
[TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamics of metronidazole determined by a time-kill assay for Trichomonas vaginalis.
Nix DE; Tyrrell R; Müller M
Antimicrob Agents Chemother; 1995 Aug; 39(8):1848-52. PubMed ID: 7486930
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of metronidazole-resistant Trichomonas vaginalis in a gynecology clinic.
Schmid G; Narcisi E; Mosure D; Secor WE; Higgins J; Moreno H
J Reprod Med; 2001 Jun; 46(6):545-9. PubMed ID: 11441678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
